Serina Therapeutics, Inc. (SER) stock
SERNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.36−0.05 (-3.87%)
Close on Nov 17, 2026Market cap $34.67MP/E –Yield –
Serina Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Serina Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $130.00K. For fiscal 2025 it was $130.00K, up 132.1% from the year before. The highest annual figure on record is $3.15M in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $130.00K | +132.1% |
| FY2024 | Dec 31, 2024 | $56.00K | -98.2% |
| FY2023 | Dec 31, 2023 | $3.15M | +9173.5% |
| FY2022 | Dec 31, 2022 | $34.00K | -76.4% |
| FY2021 | Dec 31, 2021 | $144.00K | -60.1% |
| FY2020 | Dec 31, 2020 | $361.00K | -79.1% |
| FY2019 | Dec 31, 2019 | $1.73M | +23.8% |
| FY2018 | Dec 31, 2018 | $1.40M | -0.6% |
| FY2017 | Dec 31, 2017 | $1.40M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0 | – |
| Q4 FY2025 | Dec 31, 2025 | $0 | -100.0% |
| Q3 FY2025 | Sep 30, 2025 | $0 | -100.0% |
| Q2 FY2025 | Jun 30, 2025 | $130.00K | +2500.0% |
| Q1 FY2025 | Mar 31, 2025 | $0 | -100.0% |
| Q3 FY2024 | Sep 30, 2024 | $14.00K | -51.7% |
| Q2 FY2024 | Jun 30, 2024 | $51.00K | +628.6% |
| Q1 FY2024 | Mar 31, 2024 | $5.00K | -83.3% |
| Q4 FY2023 | Dec 31, 2023 | $3.09M | +38487.5% |
| Q3 FY2023 | Sep 30, 2023 | $29.00K | +222.2% |
| Q2 FY2023 | Jun 30, 2023 | $7.00K | -41.7% |
| Q1 FY2023 | Mar 31, 2023 | $30.00K | +500.0% |
| Q4 FY2022 | Dec 31, 2022 | $8.00K | -70.4% |
| Q3 FY2022 | Sep 30, 2022 | $9.00K | -62.5% |
| Q2 FY2022 | Jun 30, 2022 | $12.00K | -67.6% |
| Q1 FY2022 | Mar 31, 2022 | $5.00K | -91.1% |
| Q4 FY2021 | Dec 31, 2021 | $27.00K | -82.9% |
| Q3 FY2021 | Sep 30, 2021 | $24.00K | -65.2% |
| Q2 FY2021 | Jun 30, 2021 | $37.00K | -17.8% |
| Q1 FY2021 | Mar 31, 2021 | $56.00K | -37.1% |
| Q4 FY2020 | Dec 31, 2020 | $158.00K | -71.2% |
| Q3 FY2020 | Sep 30, 2020 | $69.00K | -83.2% |
| Q2 FY2020 | Jun 30, 2020 | $45.00K | -88.2% |
| Q1 FY2020 | Mar 31, 2020 | $89.00K | -77.1% |
| Q4 FY2019 | Dec 31, 2019 | $549.00K | +75.4% |
| Q3 FY2019 | Sep 30, 2019 | $411.00K | +8.2% |
| Q2 FY2019 | Jun 30, 2019 | $380.00K | -18.1% |
| Q1 FY2019 | Mar 31, 2019 | $388.00K | +62.3% |
| Q4 FY2018 | Dec 31, 2018 | $313.00K | – |
| Q3 FY2018 | Sep 30, 2018 | $380.00K | – |
| Q2 FY2018 | Jun 30, 2018 | $464.00K | – |
| Q1 FY2018 | Mar 31, 2018 | $239.00K | – |
See a number that looks wrong?